Optios
Optios is a NeuroPerformance company that uses proprietary, cutting-edge neurotechnology to help elite performers unlock their brain’s exponential capacity and optimize their performance. With a mission to build an intellectual framework supporting the next phase in human development, Optios applies neuroscience to enhance human performance, cognition, creativity, learning speed, health, and longevity. The company has a strong research background, including work at DARPA, and holds numerous patents. It aims to provide a competitive edge through brain rewiring and neurofeedback systems, targeting elite athletes, organizations, and professionals.
Industries
Nr. of Employees
small (1-50)
Optios
San Diego, California, United States, North America
Patents
Identifying and strengthening physiological/neurophysiological states predictive of superior performance
US-12376775-B2
View DetailsIdentifying and strengthening physiological/neurophysiological states predictive of superior performance
US-11602293-B2
View DetailsMethod for predicting efficacy of a stimulus by measuring physiological response to stimuli
US-10835147-B1
View Details
Identifying and strengthening physiological/neurophysiological states predictive of superior performance
US-12376775-B2
View DetailsIdentifying and strengthening physiological/neurophysiological states predictive of superior performance
US-11602293-B2
View DetailsMethod for predicting efficacy of a stimulus by measuring physiological response to stimuli
US-10835147-B1
View DetailsServices
A multi-week program combining baseline neuro and mechanics assessments, in-person workshops, remote at-home training, and hands-on coaching to improve putting via brain-state training and mechanical refinement.
Employee-focused neurocognitive training and assessment interventions using computer-based cognitive training, EEG monitoring, and standardized task batteries to measure cognitive changes.
Collaborative research, study design, data analysis, and scientific dissemination services for organizations seeking to evaluate or apply neuroperformance interventions.
Organization and execution of multi-day workshops and experiential training events at external venues, integrating coaching, assessments, and hospitality.
A multi-week program combining baseline neuro and mechanics assessments, in-person workshops, remote at-home training, and hands-on coaching to improve putting via brain-state training and mechanical refinement.
Employee-focused neurocognitive training and assessment interventions using computer-based cognitive training, EEG monitoring, and standardized task batteries to measure cognitive changes.
Collaborative research, study design, data analysis, and scientific dissemination services for organizations seeking to evaluate or apply neuroperformance interventions.
Organization and execution of multi-day workshops and experiential training events at external venues, integrating coaching, assessments, and hospitality.
Expertise Areas
- Neurofeedback training
- EEG assessment and analysis
- Applied neuroscience research
- AI-driven neuroanalytics
Key Technologies
- Electroencephalography (EEG)
- Neurofeedback
- AI-driven analytics
- Neuroimaging tools
News & Updates
Optios partnered with the Leaders Performance Institute to advance awareness of how applied neuroscience optimizes peak performance in elite sports.
A study evaluating neurocognitive training programs at Fujitsu, demonstrating positive benefits in neurocognitive task performance and brain network connectivity.
Over $300M of Scientific Research and Patents
Optios has derived its proprietary technology from over $300 million of scientific research and holds dozens of patents.
Optios partnered with the Leaders Performance Institute to advance awareness of how applied neuroscience optimizes peak performance in elite sports.
A study evaluating neurocognitive training programs at Fujitsu, demonstrating positive benefits in neurocognitive task performance and brain network connectivity.
Over $300M of Scientific Research and Patents
Optios has derived its proprietary technology from over $300 million of scientific research and holds dozens of patents.